Published in Blood on December 01, 1988
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59
The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci U S A (1995) 4.21
Hematopoietic cytokines. Blood (2008) 2.45
Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci U S A (1993) 2.25
Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine (2008) 1.95
The colony-stimulating factors and cancer. Nat Rev Cancer (2010) 1.44
The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase. J Mol Biol (2008) 1.39
Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony-stimulating factors. Proc Natl Acad Sci U S A (1991) 1.32
Infection mobilizes hematopoietic stem cells through cooperative NOD-like receptor and Toll-like receptor signaling. Cell Host Microbe (2014) 1.30
Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia. Int J Nanomedicine (2015) 1.08
β-blockade protection of bone marrow following trauma: the role of G-CSF. J Surg Res (2011) 1.06
Control of myeloid-specific integrin alpha Mbeta 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1. J Biol Chem (2002) 1.04
Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice. J Clin Invest (1989) 1.02
Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients. Saudi J Gastroenterol (2008) 1.00
The hematopoietic stem cell niche. Front Biosci (Landmark Ed) (2012) 1.00
Bcr/Abl expression stimulates integrin function in hematopoietic cell lines. J Clin Invest (1996) 0.99
Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies. World J Transplant (2013) 0.98
Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing. Biomed Res Int (2013) 0.94
Nonnative protein polymers: structure, morphology, and relation to nucleation and growth. Biophys J (2007) 0.92
Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial. Ann Hematol (2010) 0.89
Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis. Exp Hematol (2010) 0.89
Modulation of c-kit mRNA and protein by hemopoietic growth factors. Mol Cell Biol (1991) 0.87
Current clinical indications for plerixafor. Transfus Med Hemother (2013) 0.86
Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial. Ann Hematol (2010) 0.84
Does granulocyte-colony stimulating factor administration induce damage or repair response in schistosomiasis? World J Hepatol (2010) 0.81
Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer (1992) 0.81
Hematopoietic contribution to skeletal muscle regeneration in acid alpha-glucosidase knockout mice. J Histochem Cytochem (2008) 0.81
Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: timing of harvesting and composition of the leukapheresis product. Br J Cancer (1993) 0.80
Comparison of lenograstim and filgrastim: effects on blood cell recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation. J Cancer Res Clin Oncol (2004) 0.80
Exogenous endothelial cells as accelerators of hematopoietic reconstitution. J Transl Med (2012) 0.79
An assessment of the pharmacokinetics, pharmacodynamics, and tolerability of GCPGC, a novel pegylated granulocyte colony-stimulating factor (G-CSF), in healthy subjects. Invest New Drugs (2014) 0.79
CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1. Exp Hematol (2012) 0.79
The potential role of recombinant hematopoietic colony-stimulating factors in preventing infections in the immunocompromised host. Can J Infect Dis (1991) 0.78
Hematopoietic growth factors in cancer patients with invasive fungal infections. Eur J Clin Microbiol Infect Dis (1997) 0.78
Concise review: Sowing the seeds of a fruitful harvest: hematopoietic stem cell mobilization. Stem Cells (2013) 0.78
Peripheral blood stem cell transplants. J Clin Pathol (1998) 0.77
The discovery, development and clinical applications of granulocyte colony-stimulating factor. Trans Am Clin Climatol Assoc (1998) 0.77
Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours. Br J Cancer (1993) 0.77
The colony-stimulating factors and cancer. Cancer Immunol Res (2013) 0.76
Supportive care in patients with acute leukaemia: historical perspectives. Blood Transfus (2014) 0.76
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim. Ther Clin Risk Manag (2016) 0.75
Autologous peripheral blood stem cell harvest: Collection efficiency and factors affecting it. Asian J Transfus Sci (2016) 0.75
Donald Metcalf: The father of modern hematology. Proc Natl Acad Sci U S A (2015) 0.75
Mobilization of Peripheral Blood Stem Cells Using Regimen Combining Docetaxel with Granulocyte Colony-stimulating Factor in Breast Cancer Patients. Chin J Cancer Res (2011) 0.75
Stress and Non-Stress Roles of Inflammatory Signals during HSC Emergence and Maintenance. Front Immunol (2016) 0.75
A study of ovarian cancer patients treated with dose-intensive chemotherapy supported with peripheral blood progenitor cells mobilised by filgrastim and cyclophosphamide. Br J Cancer (1996) 0.75
Phenotypic and functional comparison of mobilized peripheral blood versus umbilical cord blood megakaryocyte populations. Cytotherapy (2014) 0.75
Disseminated fusariosis and endogenous fungal endophthalmitis in acute lymphoblastic leukemia following platelet transfusion possibly due to transfusion-related immunomodulation. BMC Ophthalmol (2011) 0.75
Ubiquitin fusion expression and tissue-dependent targeting of hG-CSF in transgenic tobacco. BMC Biotechnol (2011) 0.75
A (selective) history of Australian involvement in cytokine biology. Cytokine Growth Factor Rev (2013) 0.75
The E. Donnall Thomas lecture: normal and neoplastic stem cells. Biol Blood Marrow Transplant (2008) 0.75
G-CSF and GM-CSF in clinical trials. Yale J Biol Med (1991) 0.75
Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropenia. Oncotarget (2017) 0.75
Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations. Stem Cells Int (2017) 0.75
Ephrin ligands and Eph receptors contribution to hematopoiesis. Cell Mol Life Sci (2017) 0.75
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature (1988) 13.21
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science (1999) 11.96
The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci (1966) 9.68
A family of cytokine-inducible inhibitors of signalling. Nature (1997) 9.22
Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J (1987) 7.45
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med (1996) 7.09
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med (1994) 6.59
Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med (1980) 5.80
Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev (1995) 5.51
Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N Engl J Med (1992) 4.54
The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood (1986) 4.47
Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor. Nature (1984) 4.46
Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A (1998) 4.38
Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol (1970) 4.32
Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature (1984) 4.29
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell (1999) 4.29
Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A (1994) 4.19
Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation (2000) 4.16
The granulocyte-macrophage colony-stimulating factors. Science (1985) 4.13
The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A (1999) 3.91
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet (1992) 3.76
Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem (1977) 3.74
Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A (1995) 3.47
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood (2000) 3.45
Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci U S A (1999) 3.45
Structure and expression of the mRNA for murine granulocyte-macrophage colony stimulating factor. EMBO J (1985) 3.30
The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. Cell (1992) 3.20
Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood (1996) 3.14
A transplantable myelomonocytic leukemia in BALB-c mice: cytology, karyotype, and muramidase content. J Natl Cancer Inst (1969) 3.06
Studies on colony formation in vitro by mouse bone marrow cells. II. Action of colony stimulating factor. J Cell Physiol (1970) 3.05
Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem (1983) 2.97
The nature and action of granulocyte-macrophage colony stimulating factors. Blood (1980) 2.94
Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem (1994) 2.82
Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J (1999) 2.80
Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci U S A (1998) 2.79
Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A (1996) 2.68
Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet (1994) 2.66
Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature (1995) 2.65
Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci U S A (2000) 2.58
Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A (1996) 2.57
Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity. Cell (1985) 2.55
Pure and mixed erythroid colony formation in vitro stimulated by spleen conditioned medium with no detectable erythropoietin. Proc Natl Acad Sci U S A (1977) 2.55
Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med (1997) 2.52
Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J (2000) 2.50
Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci U S A (1998) 2.48
Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood (1986) 2.45
Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J Immunol (1983) 2.44
Growth of B-lymphocyte colonies in vitro. J Exp Med (1975) 2.41
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res (1997) 2.40
Growth of mouse megakaryocyte colonies in vitro. Proc Natl Acad Sci U S A (1975) 2.38
Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell (1985) 2.36
Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature (1994) 2.35
Structural determinants of protein dynamics: analysis of 15N NMR relaxation measurements for main-chain and side-chain nuclei of hen egg white lysozyme. Biochemistry (1995) 2.31
Measuring outcomes: one month survival after acute myocardial infarction in Scotland. Heart (1996) 2.30
Acute antigen-induced elevation of serum colony stimulating factor (CFS) levels. Immunology (1971) 2.28
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet (1988) 2.28
Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood (1986) 2.26
Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol (1987) 2.25
"I don't like Mondays"-day of the week of coronary heart disease deaths in Scotland: study of routinely collected data. BMJ (2000) 2.25
Growth of B lymphocyte colonies in vitro from mouse lymphoid organs. Nature (1975) 2.24
Colony formation in vitro by myelomonocytic leukemic cells. J Natl Cancer Inst (1969) 2.21
Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. Cell (1993) 2.20
Genetic instability of microsatellites in endometrial carcinoma. Cancer Res (1993) 2.20
Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol (2001) 2.17
A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J (1989) 2.13
Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging (1992) 2.11
Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci U S A (2001) 2.09
The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur J Immunol (1997) 2.08
Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood (1999) 2.06
Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukemic cell lines. J Biol Chem (1988) 2.05
Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood (1977) 2.05
Separation of functionally distinct human granulocyte-macrophage colony-stimulating factors. Blood (1979) 2.05
Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun (1988) 2.04
Subunit promiscuity among hemopoietic growth factor receptors. Cell (1991) 2.03
Colony formation by human T lymphocytes in agar medium. Clin Exp Immunol (1977) 2.03
Production of colony-stimulating factor in mitogen-stimulated lymphocyte cultures. J Immunol (1974) 2.02
Fractionation of hemagglutinating and bacterial binding adhesins of Bacteroides gingivalis. Infect Immun (1984) 1.99
Filgrastim (r-metHuG-CSF): the first 10 years. Blood (1996) 1.99
Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci U S A (1995) 1.97
Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study. Lancet (2001) 1.96
Colony formation in agar by multipotential hemopoietic cells. J Cell Physiol (1979) 1.96
The structure and expression of the murine gene encoding granulocyte-macrophage colony stimulating factor: evidence for utilisation of alternative promoters. EMBO J (1985) 1.95
Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci U S A (1998) 1.95
A refined solution structure of hen lysozyme determined using residual dipolar coupling data. Protein Sci (2001) 1.88
Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet (1994) 1.81
Hierarchical down-modulation of hemopoietic growth factor receptors. Cell (1985) 1.80
Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood (1983) 1.80
Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1996) 1.79
A low molecular weight factor in lung-conditioned medium stimulating granulocyte and monocyte colony formation in vitro. J Cell Physiol (1973) 1.79
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet (2002) 1.77
Specific binding of the diphtheria tox regulatory element DtxR to the tox operator requires divalent heavy metal ions and a 9-base-pair interrupted palindromic sequence. Proc Natl Acad Sci U S A (1992) 1.74
Hemopoietic progenitor cells of W anemic mice studies in vivo and in vitro. J Cell Physiol (1968) 1.74
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med (1994) 1.73
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst (1999) 1.73
Studies on colony formation in vitro by mouse bone marrow cells. I. Continuous cluster formation and relation of clusters to colonies. J Cell Physiol (1969) 1.72
Delayed effect of thymectomy in adult life on immunological competence. Nature (1965) 1.70